COVID-19 vaccination in Spain
The COVID-19 vaccination in Spain is the national vaccination strategy started on the 27th of December 2020 in order to vaccinate the country's population against COVID-19 within the international effort to fight the COVID-19 pandemic.
Date | December 27, 2020 – present |
---|---|
Duration | 1 year, 10 months and 5 days |
Location | Spain |
Cause | COVID-19 pandemic in Spain |
Target | Adult population (age 12+) and children (age 5+) |
Organised by | Ministry of Health |
Participants | 40.911.451 people |
Outcome | 86,2% partially vaccinated (1 of 2 doses) 80,7% fully vaccinated[1] (46,2% with booster dose) |
Website | Gobierno de España |
Updated in January 31, 2022 |
As of November 23, 2021, the following doses had been received: 59,296,575 Pfizer–BioNTech COVID-19 vaccine doses, 16,105,300 Moderna vaccine doses, 17,427,500 Oxford–AstraZeneca vaccine doses and 2,659,000 Janssen vaccine doses, totaling to 95,488,375 doses. Out of these doses, 75,173,640 had been administered.
The autonomous communities with the highest fully-vaccinated percentage are Asturias (85.1%) and Galicia (84.9%), while the communities with the lowest percentage are the Canary Islands (75.7%) and the Balearic Islands (72.4%). The Spanish average percentage was 79.1%, amounting to 37,557,243 people.
Out of the total, 3,776,118 have been administered as additional doses, or third doses, of which 3,319,229 are Pfizer–BioNTech COVID-19 vaccine doses and 456,889 are Moderna vaccine doses.
The amount of doses ordered from Q1 to Q4 of 2021 is 141,943,261.
Vaccines on order
There are several COVID-19 vaccines at various stages of development around the world.
Vaccine | Doses ordered | Approval | Deployment | Age Applied[2] |
---|---|---|---|---|
Pfizer–BioNTech | 146 million | 21 December 2020 | 27 December 2020 | 12+ |
Moderna | 52 million | 6 January 2021 | 12 January 2021 | 12+ |
Oxford-AstraZeneca | 31 million | 29 January 2021 | 7 February 2021 | 60–69 |
Janssen | 20 million | 11 March 2021 | 5 May 2021 | 40+ |
Novavax | 2,2 million | 20 December 2021 | Pending | Pending |
Valneva | Pending | Pending | Pending | Pending |
Sanofi–GSK | Pending | Pending | Pending | Pending |
CureVac | Request withdrawn | Request withdrawn | No | No |
Phases and development of the vaccination campaign
According to the Government of Spain, the vaccination campaign, which is being carried out voluntarily, is structured in four phases. These phases are at the same time formed by different population groups defined in the National COVID-19 Vaccination Strategy :[3]
Phases | Population group | Development[lower-alpha 1] | ||
---|---|---|---|---|
1st doses | 2nd doses[lower-alpha 2] | |||
0 | Development, approval and assessment. | |||
1 | Priority groups | Elderly and disabled care homes' residents and staff | Completed (99,3%)[lower-alpha 3] | Completed (92,0%)[lower-alpha 3] |
First line health and socio-sanitary professionals | Completed | Completed | ||
Other health and socio-sanitary professionals | Completed | Completed | ||
Highly dependent people not living in care homes | Completed | Completed | ||
2
(In progress) |
Other priority groups | All those aged 80 and older | >100,0%[lower-alpha 4] | >100,0%[lower-alpha 4] |
All those aged between 70 and 79 and those with very high risk conditions | 99,1%[lower-alpha 5] | 98,2%[lower-alpha 5] | ||
All those aged between 60 and 69 | 97,9% | 95,1% | ||
Other health and socio-sanitary professionals | Completed | Completed | ||
Workers with an essential social role | Completed | Completed | ||
All those aged between 50 and 59 | 97,4% | 93,1% | ||
3
(In progress) |
Rest of priority groups | All those aged between 40 and 49 | 88,9% | 85,6% |
All those aged between 30 and 39 | 74,4% | 72,7% | ||
All those aged between 20 and 29 | 73,0% | 70,0% | ||
All those aged between 12 and 19 | 80,7% | 77,2% | ||
TOTALS | ||||
Current prioritary goal (all those aged 40 and over) | 94,2% | 92,1% | ||
Target population (all those aged 12 and over) | 90,8% | 85,5% | ||
Spanish total population | 79,5% | 77,3% |
Notes: The information shown in the table is collected up to September 1, 2021.
- When a group is classified as "completed", this is done based on the data reflected on the Sixth Edition of the National COVID-19 Vaccination Strategy and the Ministry of Health reports. Obviously, new incorporations to priority groups, as well as people who decide to change their initial position about receiving the vaccine, may not fulfill this classification.
- When vaccinated, those who receive the Janssen vaccine, which requires just a single dose, are counted both in first and second doses.
- Weekly updates are made available by the Ministry of Health about the vaccination index among those living in care homes (residents of elderly and disabled nursing homes). The difference between 100% and the current index is due to new residents, who are vaccinated when they move to these centres.
- The index is higher than 100%, since the census used for its computation is the most recent one prepared by the National Statistics Institute (INE), which may be a bit outdated, since it was elaborated in 2020.[4]
- The vaccination index of this priority group is referred to those aged between 70 and 79 years old. It does not include those who have very high risk conditions for their health. However, the current National Strategy determines that their vaccination must be carried out at the same time for both groups, so it is expected that the vaccination index among those with risk conditions is quite similar or higher.
Public opinion
Centre for Sociological Research
According to the Centre for Sociological Research, the Spanish public organism in charge of investigating the public opinion of the society on many different topics, these are the data of the acceptance of the vaccine among the Spanish population:
Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|
YES | Yes | 40,2% | 36,8% | 40,5% | 72,5% | 82,9% | 82,5% | 70,4% | 53,2% | 37,8% |
They are already vaccinated | – | – | – | – | – | 5,1% | 15,0% | 37,7% | 55,1% | |
Yes, depending on the origin of the vaccine | 0,2% | 0,1% | 0,6% | 0,2% | 0,4% | 0,6% | 2,4% | 1,2% | 0,4% | |
Yes, if there are guarantees, if it is proven, if it is reliable | 2,2% | 1,4% | 16,2% | 2,5% | 1,8% | 0,9% | 1,6% | 0,5% | 0,2% | |
Yes, on the advice of the authorities, scientists or health professionals | 0,2% | 0,3% | 3,6% | 1,3% | 0,9% | 0,3% | 0,4% | 0,3% | 0,1% | |
Yes, if there is enough information | 0,2% | 0,0% | 3,2% | 0,8% | 0,4% | 0,2% | 0,3% | 0,2% | 0,1% | |
TOTAL YES | 43,0% | 38,6% | 64,1% | 77,3% | 86,4% | 89,6% | 90,1% | 93,1% | 93,7% | |
NO | No | 43,8% | 47,0% | 28,0% | 16,5% | 6,5% | 5,4% | 5,3% | 3,7% | 3,6% |
TOTAL NO | 43,8% | 47,0% | 28,0% | 16,5% | 6,5% | 5,4% | 5,3% | 3,7% | 3,6% | |
NK
+ NA |
Does not know, doubts | 12,4% | 13,4% | 5,3% | 4,5% | 5,5% | 3,8% | 3,3% | 2,4% | 1,8% |
Other answers | 0,6% | 0,7% | 2,5% | 1,7% | 1,6% | 1,0% | 1,3% | 0,7% | 0,6% | |
N.A. (Not answers) | 0,4% | 0,3% | 0,1% | 0,1% | 0,1% | 0,0% | 0,1% | 0,0% | 0,1% | |
TOTAL NK/NA (OTHER ANSWERS) | 13,4% | 14,4% | 7,9% | 6,3% | 7,2% | 4,8% | 4,7% | 3,1% | 2,5% | |
Sample | 2.924 | 3.853 | 3.817 | 3.852 | 3.869 | 3.820 | 3.823 | 3.814 | 3.814 | |
Reference | [5] | [6] | [7] | [8] | [9] | [10] | [11] | [12] | [13] |
From February 2021 onwards, the centre began to ask among those who did not want to take the vaccine about the reasons they had for choosing not to receive the shot, obtaining the following results:
February 2021 | March 2021 | April 2021 | May 2021 | June 2021 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
% question | % total sample | % question | % total sample | % question | % total sample | % question | % total sample | % question | % total sample | |
They do not rely on these vaccines | 31,2% | 2,0280% | 29,3% | 1,5822% | 34,6% | 1,8338% | 25,3% | 0,9361% | 35,4% | 1,2744% |
Because of fear to develop risks for their health/side-collateral effects | 18,5% | 1,2025% | 20,1% | 1,0854% | 25,3% | 1,3409% | 25,3% | 0,9361% | 15,6% | 0,5616% |
They are against all vaccines in general | 4,3% | 0,2795% | 1,7% | 0,0981% | 3,1% | 0,1643% | 4,4% | 0,1628% | 7,1% | 0,2556% |
They prefer to wait to see how they work | 9,2% | 0,5980% | 6,0% | 0,3240% | 3,5% | 0,1855% | 7,7% | 0,2849% | 6,9% | 0,2484% |
They do not believe they are effective | 8,3% | 0,5395% | 7,1% | 0,3834% | 5,2% | 0,2756% | 8,7% | 0,3219% | 5,2% | 0,1872% |
They do not consider it necessary (without specifying) | – | – | 4,6% | 0,2484% | 3,7% | 0,1961% | 7,3% | 0,2701% | 4,7% | 0,1692% |
Because of lack of guarantees: few trials, earliness, lack of analysis | 4,6% | 0,2990% | 4,6% | 0,2484% | 3,7% | 0,1961% | 4,2% | 0,1554% | 3,1% | 0,1116% |
COVID-19 denial | – | – | 3,1% | 0,1674% | 2,8% | 0,1484% | 0,7% | 0,0259% | 3,1% | 0,1116% |
Because of having few possibilities of infection | 3,2% | 0,2080% | 3,5% | 0,1890% | 1,0% | 0,0530% | 4,8% | 0,1776% | 3,0% | 0,1080% |
Because of having allergies, other diseases or treatments, breastfeeding, pregnancy | 3,0% | 0,1950% | 2,1% | 0,1134% | 3,6% | 0,1908% | 3,7% | 0,1369% | 2,3% | 0,0828% |
Because of having passed COVID-19 | – | – | 4,6% | 0,2484% | 3,4% | 0,1802% | 0,2% | 0,0074% | 2,2% | 0,0792% |
Because of lack of information | 1,5% | 0,0975% | 3,7% | 0,1998% | 1,1% | 0,0583% | 0,7% | 0,0259% | 1,4% | 0,0504% |
There are other people more vulnerable or with a higher risk than them | 0,8% | 0,052% | 1,0% | 0,0540% | – | – | – | – | 0,8% | 0,0288% |
They do not ever get vaccinated | 1,0% | 0,0650% | 1,5% | 0,0810% | 1,6% | 0,0848% | 1,5% | 0,0555% | - | - |
Because of any other reason | 12,9% | 0,8385% | 4,9% | 0,2646% | 5,8% | 0,3074% | 3,1% | 0,1147% | 7,3% | 0,2628% |
They do not know, doubt | 1,3% | 0,0845% | 1,9% | 0,1026% | 1,0% | 0,0530% | 1,8% | 0,0666% | - | - |
N.A. (Not answers) | 0,2% | 0,0130% | – | – | 0,5% | 0,0265% | 0,8% | 0,0296% | 1,9% | 0,0684% |
Sample | 251 | 3.869 | 208 | 3.820 | 203 | 3.823 | 143 | 3.814 | 138 | 3.814 |
Reference | [9] | [10] | [11] | [12] | [13] |
Vaccinated Spanish public figures
The progress of the vaccination campaign to more and more demographic groups has allowed many public figures to receive one or two doses of the vaccine correspondent to them by age or belonging to some other priority group.
State authorities
- King Phillip VI of Spain received the vaccine on May 29, 2021, at 53 years old. The head of State received the vaccine without medical transcendence, and was only informed after receiving the jab. He was vaccinated once the access for his age group was opened, at the massive vaccination point set up in WiZink Center in Madrid, as any other citizen. He was accompanied by the head of the Royal Family medical service, Juan Martínez, and by the Vice-councillor for Public Health and COVID-19 Plan of the Community of Madrid, Antonio Zapatero. Regarding the vaccine brand, although it was not officially communicated, it is known that only Janssen vaccines were given that day. With respect to the published images, these were not distributed by the Royal Family, however, the TV programme Cuatro al día from the Spanish broadcasting station Cuatro published a picture of the head of State receiving the vaccine.
Statistics
Progress to date
References
- "Home". vacunacovid.gob.es.
- "Calendario de vacunas: llega la hora de los treintañeros y el Zendal se estrena de madrugada con más de mil pinchazos..." www.20minutos.es – Últimas Noticias. June 28, 2021.
- "¿Es obligatorio vacunarse contra el COVID-19?". Gobierno de España (in Spanish). 2020-12-27. Retrieved 2021-02-14.
- "Población por comunidades, edad (año a año), Españoles/Extranjeros, Sexo y Año". INE (in Spanish). Retrieved 2021-05-06.
- "CIS Barómetro" (PDF). October 2020. Archived (PDF) from the original on 2020-11-18.
- "CIS Barómetro" (PDF). November 2020. Archived (PDF) from the original on 2021-01-13.
- "CIS Barómetro" (PDF). December 2020. Archived (PDF) from the original on 2021-04-28.
- "CIS Barómetro" (PDF). January 2021. Archived (PDF) from the original on 2021-03-17.
- "CIS Barómetro" (PDF). February 2021. Archived (PDF) from the original on 2021-04-28.
- "CIS Barómetro" (PDF). March 2021. Archived (PDF) from the original on 2021-04-20.
- "CIS Barómetro (Avance)" (PDF). April 2021. Archived (PDF) from the original on 2021-04-19.
- "CIS Barómetro (Avance)" (PDF). May 2021. Archived (PDF) from the original on 2021-05-18.
- "CIS Barómetro (Avance)" (PDF). June 2021. Archived (PDF) from the original on 2021-06-18.
External links
- "Vacuna Covid-19" (in Spanish). Spanish Ministry of Health, Consumption and Social Welfare.
{{cite web}}
: CS1 maint: url-status (link)